A Saudi company focused on localizing biomanufacturing to ensure a steady supply of vaccines and biologics for self-sufficiency and pandemic preparedness, empowering top talent to lead sector growth in alignment with Saudi Vision 2030 and the National Biotechnology Strategy.
Founded in 2016, SVAX embarked on a mission to localize biopharmaceutical production and elevate patient care in Saudi Arabia and beyond. Driven by a vision to revolutionize healthcare through innovation, we have grown into a global leader in biotechnology, renowned for our excellence and pioneering advancements in the field
We use the latest biotech tools and technologies to develop our products and therapies. Our state-of-the-art facilities are equipped with the latest equipment and software, and our team of scientists and researchers are constantly exploring new ways to use biotech to improve healthcare outcomes.
At SVAX, we are committed to ethical and responsible biotech research and development. We believe in putting patients first, and we are dedicated to developing products and therapies that are safe, effective, and accessible to all.
SVax Innovation spearheads advanced research and development in biologics and vaccines, forging collaborations to deliver groundbreaking therapies.
SVAX Advisory Business support both local and international companies entering the Saudi market.
SVax Biomanufacturing provides cutting-edge development and manufacturing services for biologics and vaccines.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.